Groundbreaking long-acting monoclonal antibody, a collaborative effort between AstraZeneca (AZ) and Sanofi 2 min read News Groundbreaking long-acting monoclonal antibody, a collaborative effort between AstraZeneca (AZ) and Sanofi The Scientific Reporters July 19, 2023 On July 17, the U.S. Food and Drug Administration granted approval for nirsevimab, marketed under the name... Read More Read more about Groundbreaking long-acting monoclonal antibody, a collaborative effort between AstraZeneca (AZ) and Sanofi
